Oruka Therapeutics (ORKA)
Develops extended-half-life antibodies for psoriasis, hidradenitis suppurativa and related inflammatory diseases.
$92.10
Pre-market+0.38 (+0.41%)
At close$91.72(−0.42%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.58
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.49−$0.40−$0.46−$0.55−$0.45−$0.48−$0.55Pending
Estimate−$0.68−$0.57−$0.48−$0.56−$0.61−$0.52−$0.51−$0.58
Surprise+27.9%+29.8%+4.2%+1.8%+26.2%+7.7%−7.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.58 | — | — |
| Aug 2026 | −$0.51 | −$0.55 | −7.3% |
| May 2026 | −$0.52 | −$0.48 | +7.7% |
| Mar 2026 | −$0.61 | −$0.45 | +26.2% |
| Nov 2025 | −$0.56 | −$0.55 | +1.8% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.58 | — | — | — | — | — | — |
| Aug 10, 2026 | −$0.51 | −$0.55 | −7.3% | — | — | — | +6.4% |
| May 13, 2026 | −$0.52 | −$0.48 | +7.7% | — | — | — | +1.1% |
| Mar 12, 2026 | −$0.61 | −$0.45 | +26.2% | — | — | — | +25.0% |
| Nov 12, 2025 | −$0.56 | −$0.55 | +1.8% | — | — | — | −6.8% |
The latest year is open to everyone — the 34 quarters behind it read with an account. Sign in | |||||||
| Aug 11, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 27, 2024 | |||||||
| Apr 25, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||